Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
Rossi, E., Schinzari, G., Maiorano, B. A., Indellicati, G., Di Stefani, A., Pagliara, M. M., Fragomeni, S. M., De Luca, E. V., Sammarco, M. G., Garganese, G., Galli, J., Blasi, M. A., Paludetti, G., Scambia, G., Peris, K., Tortora, G., Efficacy of immune checkpoint inhibitors in different types of melanoma, <<HUMAN VACCINES & IMMUNOTHERAPEUTICS>>, 2020; 17 (1): 1-10. [doi:10.1080/21645515.2020.1771986] [http://hdl.handle.net/10807/168629]
Efficacy of immune checkpoint inhibitors in different types of melanoma
Schinzari, Giovanni;Maiorano, Brigida Anna;Di Stefani, Alessandro;Pagliara, Monica Maria;Fragomeni, Simona Maria;De Luca, Erika Valentina;Garganese, Giorgia;Galli, Jacopo;Blasi, Maria Antonietta;Paludetti, Gaetano;Scambia, Giovanni;Peris, Ketty;Tortora, Giampaolo
2020
Abstract
Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
